An apparently unprecedented restriction of future FDA spending is slated to be included in user fee reauthorization legislation.
Beginning Oct. 1, 2023, the agency will not be able to use user fee money for building maintenance and other...
FDA Faces Budget Crunch In 2023 Under User Fee Legislation
Provision would prevent FDA from using eventual fee revenue on any building maintenance costs other than leasing and scientific equipment.
